Nav: Home

Grant to TSRI-led consortium expands to $207 million

October 05, 2016

LA JOLLA, CA - October 5, 2016 - The National Institutes of Health (NIH), as part of its national Precision Medicine Initiative (PMI) Cohort Program, has expanded a five-year funding award to The Scripps Research Institute (TSRI) from $120 million to $207 million.

The award marks a significant increase in scope from the initial award announced in July and provides additional details about the network of partners in the TSRI-led consortium.

"The size of this award underscores the critical nature of this research in improving our ability to prevent and treat disease," said TSRI President Peter Schultz. "We are thrilled to be part of such a major undertaking and look forward to supporting Dr. Eric Topol in leading this unprecedented project."

Topol, who is director of the Scripps Translational Science Institute (STSI), professor of genomics at TSRI and chief academic officer at Scripps Health, will direct the award as part of the PMI Cohort Program, which seeks to engage one million or more U.S. participants in a historic medical research effort aimed at improving the ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

STSI is a National Institutes of Health-sponsored site led by TSRI and Scripps Health. This innovative research partnership is leading the effort to translate wireless and genetic medical technologies into high-quality, cost-effective treatments and diagnostics for patients.

The new award expands the group's role in overseeing the enrollment of 350,000 "direct volunteers," individuals interested in joining the PMI research study directly rather than through a healthcare provider organization. In addition, the award funds the creation of a Participant Technologies Center (PTC) to develop, test, maintain and upgrade the mobile applications and technology platform used to enroll, consent, collect data from, communicate with and retain participants. The PTC will also develop parallel platforms to deliver these same functions to those without smartphones.

"We are exceptionally fortunate to be working with an unparalleled group of partners and to be able to leverage the strengths of these leaders from a broad spectrum of sectors--pharmaceutical companies and health insurers to wireless technology experts and mobile application developers," said Topol. "The depth and breadth of expertise of these organizations will be invaluable to our goal of advancing individualized medicine at a national level."

To enroll the 350,000 "direct volunteers," Topol's team at STSI will work with:
  • Walgreens, the second largest drug store chain in the United States;

  • Leidos, QTC, the largest provider of government-outsourced occupational health and disability examination services;

  • Quintiles Quest (Q2) Solutions, the world's largest provider of biopharmaceutical development and commercial outsourcing services;

  • San Diego Blood Bank, the primary supplier of blood to hospitals in San Diego County;

  • National Blood Collaborative a national network of leading blood centers; and

  • EMSI, a leading national provider of both medical information and risk management services.

The network of partners focusing on technology development, data privacy and security, implementation and participant engagement for the study as a whole involves Walgreens, Leidos and other partners including:
  • Vibrent Health, a premier health technology platform developer;

  • Sage Bionetworks, a leader in biomedical research-related mobile-apps and platforms;

  • WebMD, a leading health and medical news publisher;

  • Blue Cross Blue Shield Association, a national federation of 36 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide healthcare coverage for more than 106 million members;

  • PatientsLikeMe, a premier online patient network;

  • Computer Science Corporation, one of the largest global healthcare system integrators and major provider of call center support; and

  • Qualcomm Inc., a leader in 4G and next-generation mobile technologies.

"Not only is the Precision Medicine Initiative the most ambitious health research program ever undertaken, it will also serve as a model for the way healthcare can be provided in the future--more convenient, less costly and more individualized," said Steven Steinhubl, director of Digital Medicine at STSI.
-end-
For more information on the Precision Medicine Initiative (PMI), visit https://www.whitehouse.gov/precision-medicine. For more information on the PMI Cohort Program and to sign up for updates, visit https://www.nih.gov/precision-medicine-initiative-cohort-program.

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists--including two Nobel laureates and 20 members of the National Academy of Science, Engineering or Medicine--work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see http://www.scripps.edu.

About Scripps Translational Science Institute

The Scripps Translational Science Institute aims to replace traditional one-size-fits-all medicine with individualized health care by leveraging the power of genomic medicine, wireless health sensors and mobile phone applications, and other digital medicine technologies. In a unique collaboration, STSI merges the considerable biomedical science expertise of The Scripps Research Institute with Scripps Health's exceptional patient care and clinical research.

Scripps Research Institute

Related Healthcare Articles:

Mitochondrial disease has a disproportionate healthcare burden in US
Mitochondrial diseases are a diverse group of disorders caused by mutated genes that impair energy production in a patient's cells, often with severe effects.
Healthcare providers should individualize patient education
Health information should be tailored to a patient's ability to understand health concepts and keep them motivated to maintain long-term changes.
High prevalence of CRE in Washington, D.C. healthcare facilities
Carbapenem-resistant Enterobacteriaceae (CRE), a family of highly pathogenic antibiotic-resistant organisms, are endemic across Washington, D.C. healthcare facilities, with 5.2 percent of inpatients testing positive for the bacteria, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Better, cheaper healthcare with dry blood samples
A drop of blood on filter paper, allowed to dry and stored for future diagnostic purposes -- considerably easier than the present-day, resource-consuming method using frozen blood samples in plastic tubes.
Undetected Ebola infection in international healthcare workers very unlikely
Undiagnosed Ebola virus infection was probably very rare in international workers who were deployed during the 2013-2015 outbreak of the virus in West Africa, despite mild and asymptomatic cases of Ebola being known to occur, according to new research led by the London School of Hygiene & Tropical Medicine.
Can we put a price on healthcare innovation in cancer?
Is there evidence that the money spent on innovation 'for the cure' actually benefits cancer patients?
Leaders in Healthcare
Join aspiring leaders to address some of the biggest issues facing healthcare leadership and management in the UK, affecting the professional workforce as well as the population.
New study: Estimated burden of healthcare-associated infections
A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.
Healthcare corruption taken to task by technology, study shows
Mobile phone technology could help to beat bad practices in healthcare delivery, research led by the University of Edinburgh suggests.
Improving LGBT healthcare for military veterans
The U.S. Veterans Health Administration (VHA), which is likely the largest provider of LGBT healthcare in the world, is implementing various system-wide changes aimed at improving LGBT care, including transgender e-consultations to aid interdisciplinary providers and the addition of a self-identified gender identity field to all veteran record systems.

Related Healthcare Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".